Cyanobacteria Lectin (MVL) Interacts with SARS-CoV-2 Spike Protein Receptor Binding Domains (RBDs) Via Protein-Protein Interaction

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Jun 27

PMID 38928400

Authors

Zhengguang Wang

Zhihan Yang

Mami Shishido

Khadija Daoudi

Masafumi Hidaka

Hiroaki Tateno

Eugene Futai

Tomohisa Ogawa

Affiliations

Soon will be listed here.

Abstract

The emergence of coronavirus disease 2019 (COVID-19) posed a major challenge to healthcare systems worldwide, especially as mutations in the culprit Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) complicated the development of vaccines and antiviral drugs. Therefore, the search for natural products with broad anti-SARS-CoV-2 capabilities is an important option for the prevention and treatment of similar infectious diseases. Lectins, which are widely recognized as antiviral agents, could contribute to the development of anti-SARS-CoV-2 drugs. This study evaluated the binding affinity of six lectins (including the cyanobacterial lectin from NIES-102 (MVL), and Jacalin, a lectin from the breadfruit, ) to the receptor binding domain (RBD) of the spike protein on the original (wild) SARS-CoV-2 and three of its mutants: Alpha, Delta, and Omicron. MVL and Jacalin showed distinct binding affinity to the RBDs of the four SARS-CoV-2 strains. The remaining four lectins (DB1, ConA, PHA-M and CSL3) showed no such binding affinity. Although the glycan specificities of MVL and Jacalin were different, they showed the same affinity for the spike protein RBDs of the four SARS-CoV-2 strains, in the order of effectiveness Alpha > Delta > original > Omicron. The verification of glycan-specific inhibition revealed that both lectins bind to RBDs by glycan-specific recognition, but, in addition, MVL binds to RBDs through protein-protein interactions.

References

Garrison A, Giomarelli B, Lear-Rooney C, Saucedo C, Yellayi S, Krumpe L . The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Res. 2014; 112:1-7. PMC: 4258435. DOI: 10.1016/j.antiviral.2014.09.012. View

Gstottner C, Zhang T, Resemann A, Ruben S, Pengelley S, Suckau D . Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells. Anal Chem. 2021; 93(17):6839-6847. PMC: 8078197. DOI: 10.1021/acs.analchem.1c00893. View

Yamaguchi M, Ogawa T, Muramoto K, Kamio Y, Jimbo M, Kamiya H . Isolation and characterization of a mannan-binding lectin from the freshwater cyanobacterium (blue-green algae) Microcystis viridis. Biochem Biophys Res Commun. 1999; 265(3):703-8. DOI: 10.1006/bbrc.1999.1749. View

Millet J, Seron K, Labitt R, Danneels A, Palmer K, Whittaker G . Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin. Antiviral Res. 2016; 133:1-8. PMC: 7113895. DOI: 10.1016/j.antiviral.2016.07.011. View

Sharon N . Lectin-carbohydrate complexes of plants and animals: an atomic view. Trends Biochem Sci. 1993; 18(6):221-6. DOI: 10.1016/0968-0004(93)90193-q. View

Dohnalek J, Skalova T . C-type lectin-(like) fold - Protein-protein interaction patterns and utilization. Biotechnol Adv. 2022; 58:107944. DOI: 10.1016/j.biotechadv.2022.107944. View

Sato Y, Hirayama M, Morimoto K, Hori K . The OAAH Family: Anti-Influenza Virus Lectins. Methods Mol Biol. 2020; 2132:683-693. DOI: 10.1007/978-1-0716-0430-4_59. View

Ferir G, Palmer K, Schols D . Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C. Virology. 2011; 417(2):253-8. DOI: 10.1016/j.virol.2011.07.004. View

Jackson C, Farzan M, Chen B, Choe H . Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2021; 23(1):3-20. PMC: 8491763. DOI: 10.1038/s41580-021-00418-x. View

10.

Pia Lenza M, Oyenarte I, Diercks T, Quintana J, Gimeno A, Coelho H . Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins. Angew Chem Int Ed Engl. 2020; 59(52):23763-23771. PMC: 7894318. DOI: 10.1002/anie.202011015. View

11.

Pal M, Berhanu G, Desalegn C, Kandi V . Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020; 12(3):e7423. PMC: 7182166. DOI: 10.7759/cureus.7423. View

12.

Chan K, Dorosky D, Sharma P, Abbasi S, Dye J, Kranz D . Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science. 2020; 369(6508):1261-1265. PMC: 7574912. DOI: 10.1126/science.abc0870. View

13.

Derewenda Z, Yariv J, Helliwell J, Kalb A, Dodson E, Papiz M . The structure of the saccharide-binding site of concanavalin A. EMBO J. 1989; 8(8):2189-93. PMC: 401146. DOI: 10.1002/j.1460-2075.1989.tb08341.x. View

14.

Cai Y, Xu W, Gu C, Cai X, Qu D, Lu L . Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit. Virol Sin. 2020; 35(6):857-860. PMC: 7554295. DOI: 10.1007/s12250-020-00305-3. View

15.

Gaidamashvili M, Ohizumi Y, Iijima S, Takayama T, Ogawa T, Muramoto K . Characterization of the yam tuber storage proteins from Dioscorea batatas exhibiting unique lectin activities. J Biol Chem. 2004; 279(25):26028-35. DOI: 10.1074/jbc.M402139200. View

16.

Noman A, Aqeel M, Khalid N, Hashem M, Alamari S, Zafar S . Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival. Microb Pathog. 2020; 150:104719. PMC: 7764473. DOI: 10.1016/j.micpath.2020.104719. View

17.

Bewley C, Cai M, Ray S, Ghirlando R, Yamaguchi M, Muramoto K . New carbohydrate specificity and HIV-1 fusion blocking activity of the cyanobacterial protein MVL: NMR, ITC and sedimentation equilibrium studies. J Mol Biol. 2004; 339(4):901-14. PMC: 2650105. DOI: 10.1016/j.jmb.2004.04.019. View

18.

Mas V, Melero J . Entry of enveloped viruses into host cells: membrane fusion. Subcell Biochem. 2013; 68:467-87. PMC: 7121288. DOI: 10.1007/978-94-007-6552-8_16. View

19.

Liu Y, Liu J, Pang X, Liu T, Ning Z, Cheng G . The roles of direct recognition by animal lectins in antiviral immunity and viral pathogenesis. Molecules. 2015; 20(2):2272-95. PMC: 6272511. DOI: 10.3390/molecules20022272. View

20.

Barre A, Van Damme E, Simplicien M, Le Poder S, Klonjkowski B, Benoist H . Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives. Cells. 2021; 10(7). PMC: 8305077. DOI: 10.3390/cells10071619. View